MSB 3.76% $1.03 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-15

  1. 2,007 Posts.
    lightbulb Created with Sketch. 313
    I smile and stamp my feet.
    I want the readouts for CHF and CLBP clinical's due mid 2020.
    While I applaud the company for giving us a next step news item, its all part of the process right?
    Anyways another feather in the bow, box ticked, curve in the road.
    Remember 4c due 31st....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.